1 – 7 of 7
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Obesity and carotid artery remodeling.
(
- Contribution to journal › Article
- 2011
-
Mark
Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study
(
- Contribution to journal › Article
- 2010
-
Mark
Changes in Prandial Glucagon Levels after 2-year Treatment with Vildagliptin or Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Monotherapy.
(
- Contribution to journal › Article
-
Mark
Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study
(
- Contribution to journal › Article
- 2009
-
Mark
Changes in prandial glucagon levels after 2 years treatment with vildagliptin or glimepiride
2009) 45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes In Diabetologia 52(Suppl 1). p.798-798(
- Contribution to journal › Published meeting abstract
-
Mark
Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy
(
- Contribution to journal › Article
- 2002
-
Mark
Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes
(
- Contribution to journal › Article